Ramus Medical Asks FDA To Expand Vascular Graft Prosthesis Definition
This article was originally published in The Gray Sheet
FDA's definition of a vascular graft prosthesis less than 6 mm in diameter should be expanded to include materials other than those currently referenced and technology used to make the prostheses, Ramus Medical Technologies maintains.
You may also be interested in...
FDA is postponing the downclassification from Class III to Class II of six cardiovascular devices pending receipt of public comments on guidance documents intended to serve as special controls for the devices.
Ramus Medical Technologies, a start-up based in Santa Barbara, California, will conduct a 10-patient study of its Rapidgraft Arterial Vessel Substitute as a replacement for a patient's radial artery in the arm when that artery has been removed for use as a coronary artery bypass graft. The purpose is to generate data to support Rapidgraft's use as a replacement vessel in CABG procedures.
Highlighting progress it has made over the past few years, Japan’s regulatory agency says it wants to raise even further the number of “Japan-first” approvals, as part of its stated mission to get safe and effective new drugs to patients more quickly.